All Stories

  1. Failure with acquired resistance of an optimised bedaquiline-based treatment regimen for pulmonary Mycobacterium avium complex disease

    Article • European Respiratory Journal, April 2019, European Respiratory Society (ERS)

    Jakko van Ingen

  2. A definition of the Mycobacterium avium complex for taxonomical and clinical purposes, a review

    Article • INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY, September 2018, Society for General Microbiology

    Jakko van Ingen

  3. Minocycline Has No Clear Role in the Treatment of Mycobacterium abscessus Disease

    Article • Antimicrobial Agents and Chemotherapy, August 2018, ASM Journals

    Jakko van Ingen

  4. Treatment outcome definitions for nontuberculous mycobacterial pulmonary disease

    Article • European Respiratory Journal, March 2018, European Respiratory Society (ERS)

    Jakko van Ingen, Professor Rachel M Thomson, Dr Enrico Tortoli, Dirk Wagner

  5. New insights in the antibiotic treatment of lung disease caused by nontuberculous mycobacteria

    Article • Future Microbiology, October 2017, Future Medicine

    Jakko van Ingen

  6. Nifurtimox -a nitrofuran antibiotic- is not active against mycobacteria

    Article • Antimicrobial Agents and Chemotherapy, June 2017, ASM Journals

    Jakko van Ingen

  7. Mycobacteria

    Article • January 2017, Elsevier

    Jakko van Ingen

  8. Nontuberculous Mycobacterial Diseases

    Article • January 2017, Elsevier

    Jakko van Ingen

  9. Physicians don't follow guidelines for the treatment of nontuberculous mycobacterial lung disease

    Article • European Respiratory Journal, December 2016, European Respiratory Society (ERS)

    Jakko van Ingen, Dirk Wagner

  10. Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry Fails To Identify Nontuberculous Mycobacteria from Primary Cultures of Respiratory Samples: TABLE 1

    Article • Journal of Clinical Microbiology, May 2016, ASM Journals

    Jakko van Ingen

  11. Skin infections caused by mycobacteria

    Article • January 2016, Springer Science + Business Media

    Jakko van Ingen

  12. Clofazimine Prevents the Regrowth of Mycobacterium abscessus and Mycobacterium avium Type Strains Exposed to Amikacin and Clarithromycin

    Article • Antimicrobial Agents and Chemotherapy, December 2015, ASM Journals

    Jakko van Ingen

  13. Regimens for nontuberculous mycobacterial lung disease lack early bactericidal activity

    Article • European Respiratory Journal, December 2015, European Respiratory Society (ERS)

    Jakko van Ingen

  14. Urinary Tract Infection Caused by a Capnophilic Proteus mirabilis Strain: TABLE 1

    Article • Journal of Clinical Microbiology, April 2015, ASM Journals

    Jakko van Ingen

  15. Treatment of pulmonary disease caused by non-tuberculous mycobacteria

    Article • The Lancet Respiratory Medicine, March 2015, Elsevier

    Jakko van Ingen

  16. Drug susceptibility testing of nontuberculous mycobacteria

    Article • Future Microbiology, September 2014, Future Medicine

    Jakko van Ingen

  17. Diagnosis of Nontuberculous Mycobacterial Infections

    Article • Seminars in Respiratory and Critical Care Medicine, March 2013, Thieme Publishing Group

    Jakko van Ingen

  18. Re-think first-line tuberculosis treatment

    Article • European Respiratory Journal, January 2013, European Respiratory Society (ERS)

    Jakko van Ingen

  19. Resistance mechanisms and drug susceptibility testing of nontuberculous mycobacteria

    Article • Drug Resistance Updates, June 2012, Elsevier

    Jakko van Ingen

  20. Characterization ofMycobacterium orygisasM. tuberculosisComplex Subspecies

    Article • Emerging Infectious Diseases, April 2012, Centers for Disease Control and Prevention (CDC)

    Jakko van Ingen

  21. Phenothiazines have antimycobacterial activity and may add acitivity to treatment regimens

    Article • Recent Patents on Anti-Infective Drug Discovery, May 2011, Bentham Science Publishers

    Jakko van Ingen